Conference Coverage
25 days ago
AAOpt 2025: Fitting irregular corneasabout 1 month ago
What ODs and MDs learned outside their specialties at EyeCon 2025Latest Content
Nov 04, 2025 | News
Sydnexis releases phase 3 STAR trial results on SYD-101 0.01% for slowing myopia progression
The Vision Council submits formal comments to US Department of Commerce on national security investigations
Nov 04, 2025
Retinal diseases in the cross hairs of optometrists at Academy 2025
Nov 04, 2025
Neurotrophic keratitis in focus: Diagnosis, treatment, and practice pearls
Nov 03, 2025
Takeaways from this week in optometry: October 27 - October 31
Nov 01, 2025
Advertisement
Shorts
0:37
Why fighting off NEI consolidation matters
2 months ago
by
Jordana Joy, Associate Editor
0:22
The Black EyeCare Perspective on allyship in eye care
2 months ago
by
Jordana Joy, Associate Editor
0:32
How to support patients who are receiving intravitreal injections
2 months ago
by
Jordana Joy, Associate Editor
0:23
Clinical findings of a novel lipid-containing eye drop
2 months ago
by
Jordana Joy, Associate Editor
0:23
Managing neuropathic corneal pain
2 months ago
by
Jordana Joy, Associate Editor
0:21
Catching toxicity in the retina before it is too late
2 months ago
by
Jordana Joy, Associate Editor
Podcasts
Videos
Optometry Times Digital Edition
NK is more common than recognized; early diagnosis is paramount.
A discussion with company executives who specialize in helping optometrists and optical shops design and launch their own branded frame collections.
Fovea-sparing, multifocal, and bilateral lesions exhibited the fastest growth rates.
Locking in correct prescriptions is as easy as checking a box.
Smart glasses with artificial intelligence assistants can make a world of difference for those with vision impairment.
A conversation with survivor and advocate Jasmine Grace Marino.
A focus on driver-based treatment provides a broader clinical framework for smarter, more personalized dry eye care.
Eye care providers are uniquely positioned to catch early risks during routine exams.
The vital role of dialogue and education in managing glaucoma.
Transforming care by integrating systemic, ocular, and emotional health can deliver personalized treatment and better outcomes.
Continuing Medical Education
All News
Advertisement
Advertisement
Regeneron faces another FDA setback for Eylea HD due to manufacturing issues, but plans for new facilities signal future production improvements.
A variety of eye drops for dry eye took the stage at this year's conference.
A discussion with company executives who specialize in helping optometrists and optical shops design and launch their own branded frame collections.
Optometrists and industry leaders alike share exciting new developments in myopia management.
Gromacki, OD, MS, FAAO, FSLS, stated that the first step to retention is asking if a patient would consider contact lens wear.
Ensuring proper hydration of the eye takes more moonlight and lullabies.
Catch up on the top stories in optometry during the week of October 20-October 24.
Jennifer Tsai, OD, details what she found surprising in the study results during AAOpt's Academy 2025 meeting.
Susan Gromacki, OD, MS, FAAO, FSLS, stated that gas-permeable (GP) lens fitting has fallen to the wayside in optometric education.
Advertisement
The FDA acknowledged the primary efficacy end point was met but determined the data did not confirm the effectiveness of low-dose atropine in children, according to the company.
Andrew Rixon, OD, FAAO, gives an overview of one of his presentations at AAOpt's Academy 2025.
Fovea-sparing, multifocal, and bilateral lesions exhibited the fastest growth rates.
Karen Hoffman, OD, provides advice for eye care providers looking to build confidence in scleral lens fitting.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Neurotrophic keratitis in focus: Diagnosis, treatment, and practice pearls
2
Retinal diseases in the cross hairs of optometrists at Academy 2025
3
The Vision Council submits formal comments to US Department of Commerce on national security investigations
4
Sydnexis releases phase 3 STAR trial results on SYD-101 0.01% for slowing myopia progression
5
.png "Optometry Times"){kind=logo}
